nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—Ponatinib—KDR—age related macular degeneration	0.0263	1	CrCbGaD
Nilotinib—EPHB2—retina—age related macular degeneration	0.0164	0.0628	CbGeAlD
Nilotinib—EPHA8—eye—age related macular degeneration	0.0159	0.0608	CbGeAlD
Nilotinib—CDC42BPB—eye—age related macular degeneration	0.0147	0.0561	CbGeAlD
Nilotinib—CDC42BPB—retina—age related macular degeneration	0.0145	0.0555	CbGeAlD
Nilotinib—EPHA3—eye—age related macular degeneration	0.0139	0.0531	CbGeAlD
Nilotinib—EPHA3—retina—age related macular degeneration	0.0138	0.0527	CbGeAlD
Nilotinib—MAPK8—eye—age related macular degeneration	0.0133	0.0507	CbGeAlD
Nilotinib—MAPK8—retina—age related macular degeneration	0.0131	0.0502	CbGeAlD
Nilotinib—MAPK8—connective tissue—age related macular degeneration	0.0128	0.0488	CbGeAlD
Nilotinib—MAP4K1—retina—age related macular degeneration	0.0119	0.0457	CbGeAlD
Nilotinib—LYN—connective tissue—age related macular degeneration	0.0118	0.0451	CbGeAlD
Nilotinib—CA3—connective tissue—age related macular degeneration	0.00869	0.0332	CbGeAlD
Nilotinib—MAPK14—connective tissue—age related macular degeneration	0.00811	0.031	CbGeAlD
Nilotinib—EPHB4—connective tissue—age related macular degeneration	0.00769	0.0294	CbGeAlD
Nilotinib—TEK—connective tissue—age related macular degeneration	0.00736	0.0281	CbGeAlD
Nilotinib—PDGFRA—connective tissue—age related macular degeneration	0.00666	0.0255	CbGeAlD
Nilotinib—CA12—eye—age related macular degeneration	0.00638	0.0244	CbGeAlD
Nilotinib—CA12—connective tissue—age related macular degeneration	0.00615	0.0235	CbGeAlD
Nilotinib—CSF1R—eye—age related macular degeneration	0.00609	0.0233	CbGeAlD
Nilotinib—CSF1R—connective tissue—age related macular degeneration	0.00587	0.0224	CbGeAlD
Nilotinib—PDGFRB—eye—age related macular degeneration	0.0054	0.0207	CbGeAlD
Nilotinib—KIT—connective tissue—age related macular degeneration	0.00533	0.0204	CbGeAlD
Nilotinib—PDGFRB—connective tissue—age related macular degeneration	0.0052	0.0199	CbGeAlD
Nilotinib—CA1—eye—age related macular degeneration	0.00506	0.0193	CbGeAlD
Nilotinib—ABL1—eye—age related macular degeneration	0.00481	0.0184	CbGeAlD
Nilotinib—ABL1—retina—age related macular degeneration	0.00477	0.0182	CbGeAlD
Nilotinib—ABL1—connective tissue—age related macular degeneration	0.00464	0.0177	CbGeAlD
Nilotinib—CA2—eye—age related macular degeneration	0.00328	0.0125	CbGeAlD
Nilotinib—CA2—retina—age related macular degeneration	0.00325	0.0124	CbGeAlD
Nilotinib—CA2—connective tissue—age related macular degeneration	0.00316	0.0121	CbGeAlD
Nilotinib—ABCB1—retina—age related macular degeneration	0.00148	0.00567	CbGeAlD
Nilotinib—MAPK8—Signaling Pathways—TGFBR1—age related macular degeneration	0.000176	0.000247	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—C3—age related macular degeneration	0.000176	0.000247	CbGpPWpGaD
Nilotinib—LYN—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000175	0.000246	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—CRP—age related macular degeneration	0.000174	0.000245	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—CD36—age related macular degeneration	0.000174	0.000244	CbGpPWpGaD
Nilotinib—HCK—Immune System—C3—age related macular degeneration	0.000173	0.000243	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CST3—age related macular degeneration	0.000172	0.000241	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000171	0.00024	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFBR1—age related macular degeneration	0.000171	0.00024	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CD36—age related macular degeneration	0.00017	0.000239	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CD36—age related macular degeneration	0.00017	0.000238	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—SQSTM1—age related macular degeneration	0.000168	0.000236	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFBR1—age related macular degeneration	0.000167	0.000235	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CD36—age related macular degeneration	0.000167	0.000235	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—TLR4—age related macular degeneration	0.000167	0.000234	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—KDR—age related macular degeneration	0.000167	0.000234	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—KDR—age related macular degeneration	0.000166	0.000233	CbGpPWpGaD
Nilotinib—MAPK14—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000166	0.000233	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD36—age related macular degeneration	0.000165	0.000232	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD36—age related macular degeneration	0.000165	0.000232	CbGpPWpGaD
Nilotinib—CA12—Metabolism—APOE—age related macular degeneration	0.000165	0.000232	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—C3—age related macular degeneration	0.000165	0.000232	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD36—age related macular degeneration	0.000165	0.000232	CbGpPWpGaD
Nilotinib—HCK—Immune System—CRP—age related macular degeneration	0.000165	0.000231	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CD36—age related macular degeneration	0.000164	0.00023	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CD36—age related macular degeneration	0.000162	0.000227	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—C3—age related macular degeneration	0.000162	0.000227	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—C3—age related macular degeneration	0.000161	0.000226	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—SQSTM1—age related macular degeneration	0.00016	0.000224	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—C3—age related macular degeneration	0.000158	0.000222	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—KDR—age related macular degeneration	0.000158	0.000222	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.000158	0.000222	CbGpPWpGaD
Nilotinib—HCK—Immune System—TLR4—age related macular degeneration	0.000158	0.000222	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.000158	0.000221	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—CRP—age related macular degeneration	0.000157	0.00022	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—C3—age related macular degeneration	0.000157	0.00022	CbGpPWpGaD
Nilotinib—BLK—Immune System—C3—age related macular degeneration	0.000157	0.00022	CbGpPWpGaD
Nilotinib—FGR—Immune System—C3—age related macular degeneration	0.000156	0.000219	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—CD36—age related macular degeneration	0.000155	0.000218	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—C3—age related macular degeneration	0.000155	0.000218	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RHO—age related macular degeneration	0.000154	0.000216	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFBR1—age related macular degeneration	0.000154	0.000216	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CRP—age related macular degeneration	0.000154	0.000216	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—C3—age related macular degeneration	0.000153	0.000215	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CRP—age related macular degeneration	0.000153	0.000215	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—SQSTM1—age related macular degeneration	0.000152	0.000213	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—SQSTM1—age related macular degeneration	0.000151	0.000212	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—SLC16A8—age related macular degeneration	0.000151	0.000211	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—TLR4—age related macular degeneration	0.00015	0.000211	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—VEGFA—age related macular degeneration	0.00015	0.00021	CbGpPWpGaD
Nilotinib—CA4—Metabolism—CD36—age related macular degeneration	0.000149	0.00021	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CRP—age related macular degeneration	0.000149	0.000209	CbGpPWpGaD
Nilotinib—BLK—Immune System—CRP—age related macular degeneration	0.000149	0.000209	CbGpPWpGaD
Nilotinib—HCK—Disease—APOE—age related macular degeneration	0.000149	0.000209	CbGpPWpGaD
Nilotinib—FGR—Immune System—CRP—age related macular degeneration	0.000149	0.000209	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000148	0.000208	CbGpPWpGaD
Nilotinib—LYN—Immune System—SQSTM1—age related macular degeneration	0.000148	0.000208	CbGpPWpGaD
Nilotinib—ABL1—Immune System—SQSTM1—age related macular degeneration	0.000147	0.000207	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—TLR4—age related macular degeneration	0.000147	0.000207	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000147	0.000207	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—TLR4—age related macular degeneration	0.000147	0.000206	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000146	0.000206	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CRP—age related macular degeneration	0.000146	0.000204	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—VEGFA—age related macular degeneration	0.000144	0.000202	CbGpPWpGaD
Nilotinib—LCK—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000143	0.000201	CbGpPWpGaD
Nilotinib—CA2—Metabolism—CD36—age related macular degeneration	0.000143	0.000201	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—TLR4—age related macular degeneration	0.000143	0.000201	CbGpPWpGaD
Nilotinib—BLK—Immune System—TLR4—age related macular degeneration	0.000143	0.000201	CbGpPWpGaD
Nilotinib—FGR—Immune System—TLR4—age related macular degeneration	0.000143	0.0002	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000141	0.000198	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—SQSTM1—age related macular degeneration	0.00014	0.000197	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFBR1—age related macular degeneration	0.00014	0.000197	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CD36—age related macular degeneration	0.00014	0.000196	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—TLR4—age related macular degeneration	0.00014	0.000196	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFBR1—age related macular degeneration	0.000139	0.000195	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000138	0.000193	CbGpPWpGaD
Nilotinib—LCK—Disease—CST3—age related macular degeneration	0.000138	0.000193	CbGpPWpGaD
Nilotinib—CA1—Metabolism—CD36—age related macular degeneration	0.000137	0.000193	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CD36—age related macular degeneration	0.000134	0.000188	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—C3—age related macular degeneration	0.000132	0.000186	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD36—age related macular degeneration	0.000132	0.000185	CbGpPWpGaD
Nilotinib—CA4—Metabolism—APOE—age related macular degeneration	0.000132	0.000185	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.00013	0.000182	CbGpPWpGaD
Nilotinib—LYN—Axon guidance—VEGFA—age related macular degeneration	0.000129	0.000181	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000129	0.000181	CbGpPWpGaD
Nilotinib—ABL1—Axon guidance—VEGFA—age related macular degeneration	0.000128	0.00018	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.000127	0.000179	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—SQSTM1—age related macular degeneration	0.000127	0.000179	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—C3—age related macular degeneration	0.000127	0.000178	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFBR1—age related macular degeneration	0.000126	0.000178	CbGpPWpGaD
Nilotinib—CA2—Metabolism—APOE—age related macular degeneration	0.000126	0.000177	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SQSTM1—age related macular degeneration	0.000126	0.000177	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CRP—age related macular degeneration	0.000126	0.000177	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—C3—age related macular degeneration	0.000125	0.000175	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—LIPC—age related macular degeneration	0.000124	0.000174	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFBR1—age related macular degeneration	0.000124	0.000174	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—VEGFA—age related macular degeneration	0.000122	0.000171	CbGpPWpGaD
Nilotinib—LCK—Immune System—SQSTM1—age related macular degeneration	0.000121	0.00017	CbGpPWpGaD
Nilotinib—CA1—Metabolism—APOE—age related macular degeneration	0.000121	0.00017	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—TLR4—age related macular degeneration	0.000121	0.00017	CbGpPWpGaD
Nilotinib—CA9—Metabolism—CD36—age related macular degeneration	0.000121	0.000169	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFBR1—age related macular degeneration	0.00012	0.000168	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CETP—age related macular degeneration	0.00012	0.000168	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000119	0.000167	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD36—age related macular degeneration	0.000119	0.000167	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CRP—age related macular degeneration	0.000119	0.000167	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000117	0.000164	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000115	0.000161	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SQSTM1—age related macular degeneration	0.000115	0.000161	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—TLR4—age related macular degeneration	0.000114	0.00016	CbGpPWpGaD
Nilotinib—KIT—Immune System—C3—age related macular degeneration	0.000113	0.000158	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD36—age related macular degeneration	0.000113	0.000158	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000111	0.000156	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SQSTM1—age related macular degeneration	0.000109	0.000152	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFBR1—age related macular degeneration	0.000108	0.000151	CbGpPWpGaD
Nilotinib—KIT—Immune System—CRP—age related macular degeneration	0.000107	0.00015	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—C3—age related macular degeneration	0.000107	0.00015	CbGpPWpGaD
Nilotinib—BRAF—Disease—APOE—age related macular degeneration	0.000106	0.000149	CbGpPWpGaD
Nilotinib—CA9—Metabolism—APOE—age related macular degeneration	0.000106	0.000149	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFBR1—age related macular degeneration	0.000106	0.000148	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—LIPC—age related macular degeneration	0.000105	0.000148	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000105	0.000147	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000104	0.000146	CbGpPWpGaD
Nilotinib—KIT—Immune System—TLR4—age related macular degeneration	0.000103	0.000144	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CRP—age related macular degeneration	0.000101	0.000142	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CETP—age related macular degeneration	0.000101	0.000142	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD36—age related macular degeneration	0.000101	0.000142	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—C3—age related macular degeneration	0.000101	0.000142	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFBR1—age related macular degeneration	0.0001	0.000141	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD36—age related macular degeneration	9.93e-05	0.000139	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD36—age related macular degeneration	9.88e-05	0.000139	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SQSTM1—age related macular degeneration	9.78e-05	0.000137	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—TLR4—age related macular degeneration	9.73e-05	0.000137	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	9.71e-05	0.000136	CbGpPWpGaD
Nilotinib—KIT—Disease—APOE—age related macular degeneration	9.68e-05	0.000136	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—C3—age related macular degeneration	9.64e-05	0.000135	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—C3—age related macular degeneration	9.61e-05	0.000135	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SQSTM1—age related macular degeneration	9.57e-05	0.000134	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—APOE—age related macular degeneration	9.44e-05	0.000133	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD36—age related macular degeneration	9.41e-05	0.000132	CbGpPWpGaD
Nilotinib—LYN—Immune System—C3—age related macular degeneration	9.41e-05	0.000132	CbGpPWpGaD
Nilotinib—ABL1—Immune System—C3—age related macular degeneration	9.36e-05	0.000131	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—KDR—age related macular degeneration	9.25e-05	0.00013	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—VEGFA—age related macular degeneration	9.19e-05	0.000129	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—APOE—age related macular degeneration	9.17e-05	0.000129	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—VEGFA—age related macular degeneration	9.15e-05	0.000128	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CRP—age related macular degeneration	9.14e-05	0.000128	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SQSTM1—age related macular degeneration	9.08e-05	0.000127	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—VEGFA—age related macular degeneration	9.01e-05	0.000127	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—APOE—age related macular degeneration	8.97e-05	0.000126	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—VEGFA—age related macular degeneration	8.97e-05	0.000126	CbGpPWpGaD
Nilotinib—LYN—Immune System—CRP—age related macular degeneration	8.95e-05	0.000126	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—C3—age related macular degeneration	8.92e-05	0.000125	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CRP—age related macular degeneration	8.91e-05	0.000125	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—KDR—age related macular degeneration	8.79e-05	0.000123	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—TLR4—age related macular degeneration	8.76e-05	0.000123	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—VEGFA—age related macular degeneration	8.71e-05	0.000122	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFBR1—age related macular degeneration	8.66e-05	0.000122	CbGpPWpGaD
Nilotinib—LYN—Immune System—TLR4—age related macular degeneration	8.58e-05	0.00012	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—VEGFA—age related macular degeneration	8.55e-05	0.00012	CbGpPWpGaD
Nilotinib—ABL1—Immune System—TLR4—age related macular degeneration	8.54e-05	0.00012	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	8.49e-05	0.000119	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	8.49e-05	0.000119	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CRP—age related macular degeneration	8.48e-05	0.000119	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	8.44e-05	0.000118	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—APOE—age related macular degeneration	8.26e-05	0.000116	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD36—age related macular degeneration	8.14e-05	0.000114	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—TLR4—age related macular degeneration	8.13e-05	0.000114	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—C3—age related macular degeneration	8.08e-05	0.000113	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—C3—age related macular degeneration	8e-05	0.000112	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CCL2—age related macular degeneration	7.93e-05	0.000111	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SQSTM1—age related macular degeneration	7.85e-05	0.00011	CbGpPWpGaD
Nilotinib—LCK—Immune System—C3—age related macular degeneration	7.71e-05	0.000108	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—LIPC—age related macular degeneration	7.7e-05	0.000108	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CCL2—age related macular degeneration	7.54e-05	0.000106	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—APOE—age related macular degeneration	7.52e-05	0.000106	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	7.49e-05	0.000105	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—APOE—age related macular degeneration	7.45e-05	0.000105	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CETP—age related macular degeneration	7.43e-05	0.000104	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—VEGFA—age related macular degeneration	7.39e-05	0.000104	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—KDR—age related macular degeneration	7.37e-05	0.000103	CbGpPWpGaD
Nilotinib—LCK—Immune System—CRP—age related macular degeneration	7.33e-05	0.000103	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—KDR—age related macular degeneration	7.3e-05	0.000102	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—C3—age related macular degeneration	7.28e-05	0.000102	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CD36—age related macular degeneration	7.18e-05	0.000101	CbGpPWpGaD
Nilotinib—LCK—Immune System—TLR4—age related macular degeneration	7.03e-05	9.87e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	6.91e-05	9.7e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—C3—age related macular degeneration	6.89e-05	9.68e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	6.84e-05	9.6e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—APOE—age related macular degeneration	6.78e-05	9.52e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—KDR—age related macular degeneration	6.64e-05	9.33e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—APOE—age related macular degeneration	6.63e-05	9.3e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—LIPC—age related macular degeneration	6.52e-05	9.16e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—APOE—age related macular degeneration	6.42e-05	9.01e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—APOE—age related macular degeneration	6.34e-05	8.9e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CCL2—age related macular degeneration	6.32e-05	8.87e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CETP—age related macular degeneration	6.29e-05	8.84e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—KDR—age related macular degeneration	6.29e-05	8.83e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CCL2—age related macular degeneration	6.26e-05	8.79e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—C3—age related macular degeneration	6.21e-05	8.72e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	6.1e-05	8.56e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CD36—age related macular degeneration	6.09e-05	8.56e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—C3—age related macular degeneration	6.08e-05	8.54e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—APOE—age related macular degeneration	5.78e-05	8.12e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—C3—age related macular degeneration	5.77e-05	8.09e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CCL2—age related macular degeneration	5.7e-05	8e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—LIPC—age related macular degeneration	5.68e-05	7.98e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—KDR—age related macular degeneration	5.67e-05	7.95e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—APOE—age related macular degeneration	5.66e-05	7.95e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—KDR—age related macular degeneration	5.55e-05	7.79e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CETP—age related macular degeneration	5.48e-05	7.7e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CCL2—age related macular degeneration	5.4e-05	7.57e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—APOE—age related macular degeneration	5.38e-05	7.55e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—APOE—age related macular degeneration	5.37e-05	7.54e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—LIPC—age related macular degeneration	5.36e-05	7.52e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—LIPC—age related macular degeneration	5.31e-05	7.45e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—KDR—age related macular degeneration	5.26e-05	7.38e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CETP—age related macular degeneration	5.17e-05	7.25e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CETP—age related macular degeneration	5.12e-05	7.19e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—VEGFA—age related macular degeneration	5.09e-05	7.15e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—C3—age related macular degeneration	4.98e-05	7e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCL2—age related macular degeneration	4.86e-05	6.82e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—VEGFA—age related macular degeneration	4.84e-05	6.8e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCL2—age related macular degeneration	4.76e-05	6.68e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—APOE—age related macular degeneration	4.64e-05	6.52e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—KDR—age related macular degeneration	4.55e-05	6.38e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCL2—age related macular degeneration	4.51e-05	6.33e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CD36—age related macular degeneration	4.47e-05	6.27e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—VEGFA—age related macular degeneration	4.06e-05	5.7e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—VEGFA—age related macular degeneration	4.02e-05	5.65e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—APOE—age related macular degeneration	3.94e-05	5.53e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCL2—age related macular degeneration	3.9e-05	5.48e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CD36—age related macular degeneration	3.78e-05	5.31e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—VEGFA—age related macular degeneration	3.66e-05	5.14e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—LIPC—age related macular degeneration	3.5e-05	4.92e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—VEGFA—age related macular degeneration	3.46e-05	4.86e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CETP—age related macular degeneration	3.38e-05	4.74e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—APOE—age related macular degeneration	3.34e-05	4.68e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CD36—age related macular degeneration	3.3e-05	4.63e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—VEGFA—age related macular degeneration	3.12e-05	4.38e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CD36—age related macular degeneration	3.11e-05	4.36e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CD36—age related macular degeneration	3.08e-05	4.32e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—VEGFA—age related macular degeneration	3.06e-05	4.29e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—APOE—age related macular degeneration	2.91e-05	4.08e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—VEGFA—age related macular degeneration	2.9e-05	4.07e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—APOE—age related macular degeneration	2.74e-05	3.85e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—APOE—age related macular degeneration	2.72e-05	3.81e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—VEGFA—age related macular degeneration	2.5e-05	3.52e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CD36—age related macular degeneration	2.03e-05	2.85e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—APOE—age related macular degeneration	1.79e-05	2.51e-05	CbGpPWpGaD
